Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer.

Autor: Skingen VE; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Salberg UB; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hompland T; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Fjeldbo CS; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Helgeland H; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Frikstad KM; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Ragnum HB; Department of Hematology and Oncology, Telemark Hospital Trust, Skien, Norway., Vlatkovic L; Department of Pathology, Oslo University Hospital, Oslo, Norway., Hole KH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Seierstad T; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Lyng H; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway.

Publikováno v: The Journal of pathology [J Pathol] 2024 Nov; Vol. 264 (3), pp. 270-283. Date of Electronic Publication: 2024 Sep 27.

Prostate cancer radiogenomics reveals proliferative gene expression programs associated with distinct MRI-based hypoxia levels.

Autor: Skingen VE; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway; Department of Physics, University of Oslo, Oslo, Norway., Hompland T; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway., Fjeldbo CS; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway., Salberg UB; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway., Helgeland H; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway., Ragnum HB; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway; Department of Oncology and Hematology, Telemark Hospital Trust, Skien, Norway., Aarnes EK; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway., Vlatkovic L; Department of Pathology, Oslo University Hospital, Oslo, Norway., Hole KH; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Seierstad T; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Lyng H; Department of Radiation Biology, Oslo University Hospital, Oslo, Norway; Department of Physics, University of Oslo, Oslo, Norway. Electronic address: heidi.lyng@rr-research.no.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Nov; Vol. 188, pp. 109875. Date of Electronic Publication: 2023 Aug 26.

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.

Autor: Mo T; Faculty of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, 4950 Oslo, Norway., Brandal SHB; Faculty of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Breast Diagnostic, Oslo University Hospital, 0379 Oslo, Norway., Geier OM; Department of Diagnostic Physics, Oslo University Hospital, 0379 Oslo, Norway., Engebråten O; Faculty of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Oncology, Oslo University Hospital, 0379 Oslo, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 4950 Oslo, Norway., Nilsen LB; Department of Medical Physics, Oslo University Hospital, 0379 Oslo, Norway., Kristensen VN; Faculty of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital, 0450 Oslo, Norway., Hole KH; Faculty of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Oncologic Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway., Hompland T; Department of Radiation Biology, Oslo University Hospital, 4950 Oslo, Norway., Fleischer T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, 4950 Oslo, Norway., Seierstad T; Department of Research and Development, Division for Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.

Publikováno v: Cancers [Cancers (Basel)] 2023 Sep 21; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 21.

Monoparametric high-resolution diffusion weighted MRI as a possible first step in an MRI-directed diagnostic pathway for men with suspicion of prostate cancer.

Autor: Reijnen JS; Department of Radiology, Sørlandet Hospital Trust, Kristiansand, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ryg U; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Radiology and Nuclear Medicine, Radiumhospitalet, Oslo University Hospital, Oslo, Norway., Marthinsen JB; Department of Radiology, Sørlandet Hospital Trust, Kristiansand, Norway., Schönhardt I; Department of Pathology, Sørlandet Hospital Trust, Kristiansand, Norway., Seierstad T; Division of Radiology and Nuclear Medicine, Radiumhospitalet, Oslo University Hospital, Oslo, Norway., Hole KH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Radiology and Nuclear Medicine, Radiumhospitalet, Oslo University Hospital, Oslo, Norway.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Jan 31; Vol. 13, pp. 1102860. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023).

Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma.

Autor: Zirakchian Zadeh M; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Asadollahi S; Johns Hopkins Medicine and The Russell H. Morgan Department of Radiology and Radiological Sciences at Johns Hopkins Medicine, Baltimore, Maryland., Kaghazchi F; Department of Radiology, Hospital of the University of Pennsylvania., Raynor WY; Department of Radiology, Hospital of the University of Pennsylvania.; Drexel University College of Medicine, Philadelphia, Pennsylvania., Mehdizadeh Seraj S; Department of Radiology & Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut, USA., Werner TJ; Department of Radiology, Hospital of the University of Pennsylvania., Seierstad T; Department of Radiology, Hospital of the University of Pennsylvania., Korostoff J; Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Swisher-McClure S; Department of Radiology, Hospital of the University of Pennsylvania., Alavi A; Department of Radiology, Hospital of the University of Pennsylvania., Revheim ME; Department of Radiology, Hospital of the University of Pennsylvania.

Publikováno v: Nuclear medicine communications [Nucl Med Commun] 2022 Jul 01; Vol. 43 (7), pp. 800-806. Date of Electronic Publication: 2022 May 13.